DacihepDaklinzaDaclatasvir 60mg, is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.

Limitations of Use: Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.

Dacihep’s brand name is Daklinza by Bristol-Myers Squibb. Dacihep is a generic oncologic prescription medicine from Zydus, which is one of the biggest pharmaceutical company in India.

Submit your review

Your email address will not be published. Required fields are marked *


There are no reviews yet.

Shop By Categories

Buy Dacihep (Daklinza) Daclatasvir 60mg online

Buy Dacihep (Daklinza) Daclatasvir 60mg online


Add to Cart